Screener
Biodesix, Inc. BDSX Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -20%+24.5pp | -26%+17.8pp | -31.5%+16.9pp | -40.6%+12.4pp | -44.5%+10.1pp | |
| Net margin | -27%+26.7pp | -33.3%+21.0pp | -39.8%+20.3pp | -49.3%+17.5pp | -53.7%+19.4pp | |
| Returns | ||||||
| Return on equity | -540%-320pp | -316.5%— | —— | —— | -219.7%— | |
| Return on invested capital | -39.8%+23.2pp | -45%+20.3pp | -51.6%+20.6pp | -57.6%+21.5pp | -63%+24.4pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.4× | 1.1×+0.2× | 1×+0.2× | 0.8×+0.1× | 0.8×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.8×+0.7× | 2.8×+0.6× | 1.9×-0.9× | 1.8×-1.6× | 2.1×-1.1× | |
| Leverage | ||||||
| Debt-to-equity | 7.9×-55.5× | 7.8×+2.2× | —— | —— | 63.4×+61.7× | |
| Per Share | ||||||
| Book value per share | $0.89+472% | $0.95-37.6% | -$0.33-110% | -$0.23-106% | $0.16-45.6% | |
| Valuation | ||||||
| Market capitalization | $322.86M+368% | $142.95M+56.6% | $54.1M-75.7% | $60.4M-76.8% | $40.33M-79.3% | |
| Price / sales | 3.1×+2.2× | 1.5×+0.3× | 0.6×-2.5× | 0.8×-3.2× | 0.5×-2.7× | |
| Price / book | 35.3×-25.3× | 15.7×+7.4× | —— | —— | 35.4×+30.1× |
FAQ
- Where do Biodesix, Inc.'s ratios come from?
- Every ratio is computed from Biodesix, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
